Your browser doesn't support javascript.
loading
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Slootbeek, Peter H J; Kloots, Iris S H; Smits, Minke; van Oort, Inge M; Gerritsen, Winald R; Schalken, Jack A; Ligtenberg, Marjolijn J L; Grünberg, Katrien; Kroeze, Leonie I; Bloemendal, Haiko J; Mehra, Niven.
Afiliação
  • Slootbeek PHJ; Radboud University Medical Centre, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, The Netherlands.
  • Kloots ISH; Radboud University Medical Centre, Radboud institute for Molecular Life sciences, Department of Experimental Urology, Nijmegen, The Netherlands.
  • Smits M; Radboud University Medical Centre, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, The Netherlands.
  • van Oort IM; Radboud University Medical Centre, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, The Netherlands.
  • Gerritsen WR; Radboud University Medical Centre, Radboud Institute for Health Sciences, Department of Urology, Nijmegen, The Netherlands.
  • Schalken JA; Radboud University Medical Centre, Radboud Institute for Health Sciences, Department of Medical Oncology, Nijmegen, The Netherlands.
  • Ligtenberg MJL; Radboud University Medical Centre, Radboud institute for Molecular Life sciences, Department of Experimental Urology, Nijmegen, The Netherlands.
  • Grünberg K; Radboud University Medical Centre, Radboud Institute for Molecular Life sciences, Department of Pathology, Nijmegen, The Netherlands.
  • Kroeze LI; Radboud University Medical Centre, Radboud Institute for Molecular Life sciences, Department of Human Genetics, Nijmegen, The Netherlands.
  • Bloemendal HJ; Radboud University Medical Centre, Radboud Institute for Molecular Life sciences, Department of Pathology, Nijmegen, The Netherlands.
  • Mehra N; Radboud University Medical Centre, Radboud Institute for Molecular Life sciences, Department of Pathology, Nijmegen, The Netherlands.
Br J Cancer ; 126(7): 1108, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35210590
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda